Due to case reports of fatal multifocal hemorrhage after thrombolysis in patients on amyloid immunotherapy, a scientific advisor from the American Heart Association recommends against the use of thrombolytic therapy. We report a stroke patient on anti-amyloid immunotherapy with a favorable clinical outcome.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: